EGFR MUTANT ADVANCED NON-SMALL CELL LUNG CANCER
Clinical trials for EGFR MUTANT ADVANCED NON-SMALL CELL LUNG CANCER explained in plain language.
Never miss a new study
Get alerted when new EGFR MUTANT ADVANCED NON-SMALL CELL LUNG CANCER trials appear
Sign up with your email to follow new studies for EGFR MUTANT ADVANCED NON-SMALL CELL LUNG CANCER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New combo therapy aims to control advanced lung cancer
Disease control Recruiting nowThis study tests whether combining two types of drugs (EGFR-TKIs and a PD-1 antibody) can help control advanced non-small cell lung cancer with specific EGFR mutations. It involves 32 adults who have not had prior treatment. The main goal is to see how long the cancer stays under…
Matched conditions: EGFR MUTANT ADVANCED NON-SMALL CELL LUNG CANCER
Phase: PHASE2 • Sponsor: Nanfang Hospital, Southern Medical University • Aim: Disease control
Last updated Jun 27, 2026 13:04 UTC
-
New drug zorifertinib aims to fight lung cancer in the brain
Disease control Recruiting nowThis study is testing a drug called zorifertinib as the first treatment for people with advanced non-small cell lung cancer that has a specific gene mutation (EGFR) and has spread to the brain or spinal cord. The trial will enroll 800 participants and compare zorifertinib to othe…
Matched conditions: EGFR MUTANT ADVANCED NON-SMALL CELL LUNG CANCER
Sponsor: Alpha Biopharma (Jiangsu) Co., Ltd. • Aim: Disease control
Last updated Jun 27, 2026 09:03 UTC